Literature DB >> 20739158

Artemisinin inhibits in vitro and in vivo invasion and metastasis of human hepatocellular carcinoma cells.

Tan Weifeng1, Shen Feng, Luo Xiangji, Su Changqing, Qiu Zhiquan, Zeng Huazhong, Yan Peining, Yu Yong, Wu Mengchao, Jiang Xiaoqing, Lau Wan-Yee.   

Abstract

Artemisinin (ART) is isolated from the medicinal plant Artemisia annua L. To determine its effects on the invasion and metastasis of tumors, the human hepatocellular carcinoma (HCC) cell lines HepG2 and SMMC-7721 were treated with different concentrations of ART. Starting at 12.5μM, ART had inhibitory effects in migration and invasion assays that increased at higher concentrations. The inhibitory effect also became stronger with time, from 24 to 72h. ART significantly inhibited the in vivo metastatic abilities of the HepG2 HCC cell line. ART inhibited the invasion and metastasis of HCC cells both in vitro and in vivo by reducing the level of the MMP2 metalloproteinase, and by inducing the TIMP2 protein. ART activated Cdc42, which enhanced E-cadherin activity, resulting in greater cell-cell adhesion, and significantly reduced metastasis. 2010. Published by Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20739158     DOI: 10.1016/j.phymed.2010.07.003

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  22 in total

1.  pH-responsive artemisinin dimer in lipid nanoparticles are effective against human breast cancer in a xenograft model.

Authors:  Yitong J Zhang; Xi Zhan; Liguo Wang; Rodney J Y Ho; Tomikazu Sasaki
Journal:  J Pharm Sci       Date:  2015-03-09       Impact factor: 3.534

2.  Holotransferrin enhances selective anticancer activity of artemisinin against human hepatocellular carcinoma cells.

Authors:  Xiao-Rong Deng; Zhao-Xia Liu; Feng Liu; Lei Pan; He-Ping Yu; Jin-Ping Jiang; Jian-Jun Zhang; Li Liu; Jun Yu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-12-13

3.  Synergic effects of artemisinin and resveratrol in cancer cells.

Authors:  Peichun Li; Sen Yang; Mengmeng Dou; Youran Chen; Jie Zhang; Xiaoyan Zhao
Journal:  J Cancer Res Clin Oncol       Date:  2014-07-22       Impact factor: 4.553

Review 4.  Development of artemisinin compounds for cancer treatment.

Authors:  Henry C Lai; Narendra P Singh; Tomikazu Sasaki
Journal:  Invest New Drugs       Date:  2012-08-31       Impact factor: 3.850

Review 5.  Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine.

Authors:  Hua Luo; Chi Teng Vong; Hanbin Chen; Yan Gao; Peng Lyu; Ling Qiu; Mingming Zhao; Qiao Liu; Zehua Cheng; Jian Zou; Peifen Yao; Caifang Gao; Jinchao Wei; Carolina Oi Lam Ung; Shengpeng Wang; Zhangfeng Zhong; Yitao Wang
Journal:  Chin Med       Date:  2019-11-06       Impact factor: 5.455

6.  ROS-Mediated Anti-Tumor Effect of Coptidis Rhizoma against Human Hepatocellular Carcinoma Hep3B Cells and Xenografts.

Authors:  So Young Kim; Cheol Park; Min Yeong Kim; Seon Yeong Ji; Hyun Hwangbo; Hyesook Lee; Su Hyun Hong; Min Ho Han; Jin-Woo Jeong; Gi-Young Kim; Chang-Gue Son; JaeHun Cheong; Yung Hyun Choi
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

Review 7.  Antitumor activity of artemisinin and its derivatives: from a well-known antimalarial agent to a potential anticancer drug.

Authors:  Maria P Crespo-Ortiz; Ming Q Wei
Journal:  J Biomed Biotechnol       Date:  2011-11-22

8.  Anticancer properties of distinct antimalarial drug classes.

Authors:  Rob Hooft van Huijsduijnen; R Kiplin Guy; Kelly Chibale; Richard K Haynes; Ingmar Peitz; Gerhard Kelter; Margaret A Phillips; Jonathan L Vennerstrom; Yongyuth Yuthavong; Timothy N C Wells
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

9.  Triptolide inhibits ovarian cancer cell invasion by repression of matrix metalloproteinase 7 and 19 and upregulation of E-cadherin.

Authors:  Hongxi Zhao; Zhifu Yang; Xiaohong Wang; Xianzhi Zhang; Meng Wang; Yukun Wang; Qibing Mei; Zhipeng Wang
Journal:  Exp Mol Med       Date:  2012-11-30       Impact factor: 8.718

10.  pH-responsive artemisinin derivatives and lipid nanoparticle formulations inhibit growth of breast cancer cells in vitro and induce down-regulation of HER family members.

Authors:  Yitong J Zhang; Byron Gallis; Michio Taya; Shusheng Wang; Rodney J Y Ho; Tomikazu Sasaki
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.